2020 AI + Health Leadership Summit

The Alliance for Artificial Intelligence in Healthcare virtually hosted its inaugural AI + Healthcare Leadership Summit on June 4, 2020. The Summit featured Amy Abernethy M.D., Ph.D., Principal Deputy Commissioner of the U.S. Food & Drug Administration, in a “fireside chat” to discuss real-world examples of AI applications in therapeutic discovery and development, and FDA perspectives on how AI can best contribute to the COVID-19 response effort. Additional perspectives on the future of AI enabled healthcare were provided by other global thought leaders in the Healthcare AI community — including AI healthcare product and service companies, pharma, medtech, platform developers, and academia — to consider and discuss opportunities to accelerate the integration of AI into the modern healthcare system. 

Previous
Previous

Opportunities for Digital Medicine and AI Healthcare in Cures 2.0

Next
Next

AAIH FDA CDS Comments